Skip to main content

Peer Review reports

From: The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov

Original Submission
23 May 2018 Submitted Original manuscript
4 Sep 2018 Reviewed Reviewer Report - Thierry Alcindor
21 Sep 2018 Reviewed Reviewer Report - Reviewer 2
31 Oct 2018 Author responded Author comments - Yi Que
Resubmission - Version 2
31 Oct 2018 Submitted Manuscript version 2
7 Nov 2018 Reviewed Reviewer Report - Reviewer 2
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
29 Nov 2018 Editorially accepted
13 Dec 2018 Article published 10.1186/s12885-018-5163-2

You can find further information about peer review here.

Back to article page